Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Xue Cathy Bai, M.D.

Concepts (127)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Melanoma33202357093.030 Why?
Skin Neoplasms15202358211.650 Why?
Cyclin-Dependent Kinase 4320215610.810 Why?
Microphthalmia-Associated Transcription Factor120192590.570 Why?
Drug Resistance, Neoplasm3202153050.500 Why?
Piperazines3202125230.450 Why?
Mucous Membrane420216590.440 Why?
Pyridines4202228750.430 Why?
Telomerase120177450.400 Why?
Glucocorticoids1202121610.390 Why?
Interferon-gamma2201931620.390 Why?
Carcinoma, Renal Cell6202431640.360 Why?
MAP Kinase Signaling System1201714860.350 Why?
Kidney Neoplasms6202442490.330 Why?
Neoplasm Staging62022111210.290 Why?
Prognosis132024296250.270 Why?
Antineoplastic Combined Chemotherapy Protocols82023117420.270 Why?
GTP Phosphohydrolases220215170.260 Why?
Promoter Regions, Genetic1201757890.260 Why?
Protein Kinase Inhibitors7202256710.250 Why?
Carcinoma, Transitional Cell220237820.250 Why?
Indoles2202318330.220 Why?
Survival Rate72021127250.220 Why?
Mutation62022300520.190 Why?
Signal Transduction32019234450.170 Why?
Retrospective Studies142024806360.170 Why?
Ureteral Neoplasms120201060.160 Why?
Vascular Endothelial Growth Factor A4202334920.160 Why?
Pyrrolidines120203380.150 Why?
Oncolytic Viruses120223440.150 Why?
Quinolines120237640.150 Why?
Humans4020247615040.140 Why?
Single-Blind Method1202115720.140 Why?
Proto-Oncogene Proteins c-kit220187270.140 Why?
Oncolytic Virotherapy120225160.130 Why?
Immunotherapy5202346520.130 Why?
Testicular Neoplasms120227990.130 Why?
Urologic Neoplasms120193140.120 Why?
Mitogen-Activated Protein Kinase Kinases120176410.120 Why?
Tumor Burden1202118930.120 Why?
Cyclic AMP1201914630.120 Why?
Angiogenesis Inhibitors2202220470.120 Why?
Adenocarcinoma, Mucinous120185170.110 Why?
Radiographic Image Interpretation, Computer-Assisted1202112220.110 Why?
Time Factors52022399670.110 Why?
Pyrroles1202011250.110 Why?
Deoxycytidine120188770.110 Why?
Follow-Up Studies62021391060.110 Why?
Antineoplastic Agents42021136390.110 Why?
Combined Modality Therapy2202285290.110 Why?
Aged1520211692890.100 Why?
Membrane Proteins2202178560.100 Why?
Esophageal Neoplasms1202316540.100 Why?
Middle Aged1720232208950.100 Why?
Cisplatin1201816510.100 Why?
Proto-Oncogene Proteins B-raf2202220570.100 Why?
Bone Neoplasms1202425290.100 Why?
Radiosurgery1202113420.090 Why?
Urinary Bladder Neoplasms1202322230.090 Why?
Brain Neoplasms2202290310.090 Why?
Adult1420212211770.090 Why?
Male1920233608040.090 Why?
DNA Copy Number Variations1201820200.080 Why?
China3202123690.080 Why?
Tumor Microenvironment1202238770.080 Why?
DNA Mutational Analysis1201741110.080 Why?
Female1820223926440.080 Why?
Boston1202193260.070 Why?
Disease Progression22021135060.070 Why?
Immunoglobulin G1201945440.070 Why?
Antibodies, Monoclonal1202391770.070 Why?
Predictive Value of Tests12021152660.060 Why?
Kaplan-Meier Estimate3202164840.060 Why?
Aged, 80 and over42021589760.050 Why?
Neoplasm Recurrence, Local2202092800.050 Why?
Models, Biological1201994690.050 Why?
MicroRNAs1201938160.050 Why?
Lymphatic Metastasis2202029150.050 Why?
Leukopenia120202130.040 Why?
Young Adult32021592430.040 Why?
Risk Assessment12021239950.040 Why?
Survival Analysis22022100900.040 Why?
Nails120202960.040 Why?
Calcium-Binding Proteins1202310690.040 Why?
Carboplatin120217940.040 Why?
Lung Neoplasms12022133800.040 Why?
Cyclin D1120194510.040 Why?
Drug Synergism1202117550.040 Why?
Risk Factors22022742060.040 Why?
Proteinuria120206070.040 Why?
Translocation, Genetic1202213930.030 Why?
Cyclin-Dependent Kinase Inhibitor p16120196980.030 Why?
Foot120205750.030 Why?
Microarray Analysis120197490.030 Why?
Protein Kinases1202316080.030 Why?
Sentinel Lymph Node Biopsy120207320.030 Why?
Treatment Outcome52021646800.030 Why?
Hand120209020.030 Why?
Infusions, Intravenous1201922190.030 Why?
Gene Amplification1201810890.030 Why?
Gene Dosage1201712170.030 Why?
Paclitaxel1202117320.030 Why?
Hypercholesterolemia1202011410.030 Why?
Drug Administration Schedule1202048530.020 Why?
Hyperglycemia1202013760.020 Why?
Tumor Cells, Cultured1201961320.020 Why?
Prospective Studies32022544250.020 Why?
Lymph Nodes1202234660.020 Why?
Neoplasm Invasiveness1201835950.020 Why?
Tumor Necrosis Factor-alpha1201943520.020 Why?
Lymphocyte Activation1201954860.020 Why?
Proteins1202360320.020 Why?
Neoplasm Metastasis1201849150.020 Why?
Sirolimus1201415330.020 Why?
Adolescent32021883190.020 Why?
Biopsy1201967660.020 Why?
Dose-Response Relationship, Drug12019107660.020 Why?
TOR Serine-Threonine Kinases1201420570.020 Why?
CD8-Positive T-Lymphocytes1201945800.020 Why?
Incidence12022213530.010 Why?
Disease-Free Survival1201468140.010 Why?
Proportional Hazards Models12018124630.010 Why?
Gene Expression Profiling1201994200.010 Why?
Mice22019815250.010 Why?
Cell Line, Tumor12017169810.010 Why?
Animals220191684590.010 Why?
Child12018801530.010 Why?
Bai's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (127)
Explore
_
Co-Authors (4)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.